EP2696753B1 - System for ELECTROPHYSIOLOGICAL SIGNAL PROCESSING AND UTILIZATION OF A MONOPHASIC ACTION POTENTIAL - Google Patents
System for ELECTROPHYSIOLOGICAL SIGNAL PROCESSING AND UTILIZATION OF A MONOPHASIC ACTION POTENTIAL Download PDFInfo
- Publication number
- EP2696753B1 EP2696753B1 EP12716167.7A EP12716167A EP2696753B1 EP 2696753 B1 EP2696753 B1 EP 2696753B1 EP 12716167 A EP12716167 A EP 12716167A EP 2696753 B1 EP2696753 B1 EP 2696753B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- control unit
- action potential
- image
- monophasic action
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036982 action potential Effects 0.000 title claims description 33
- 238000012545 processing Methods 0.000 title description 12
- 210000003484 anatomy Anatomy 0.000 claims description 23
- 230000028161 membrane depolarization Effects 0.000 claims description 14
- 238000004891 communication Methods 0.000 claims description 11
- 230000002336 repolarization Effects 0.000 claims description 7
- 238000000718 qrs complex Methods 0.000 claims 2
- 238000000034 method Methods 0.000 description 21
- 238000009877 rendering Methods 0.000 description 12
- 238000003384 imaging method Methods 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000000007 visual effect Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000013152 interventional procedure Methods 0.000 description 4
- 238000002595 magnetic resonance imaging Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 3
- 238000012806 monitoring device Methods 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 238000006213 oxygenation reaction Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 102000004310 Ion Channels Human genes 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000004457 myocytus nodalis Anatomy 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000004375 bundle of his Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 208000004731 long QT syndrome Diseases 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 230000036279 refractory period Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
- A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/33—Heart-related electrical modalities, e.g. electrocardiography [ECG] specially adapted for cooperation with other devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
- A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/12—Arrangements for detecting or locating foreign bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
- A61B8/0841—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0883—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of the heart
Definitions
- the present invention relates generally to medical systems, and more particularly to obtaining, processing and displaying electrophysiological information for clinical use.
- instrumentation modalities used to image patient anatomy and physiology include 1) X-ray (radiation transmitted through a body and received with a sensor to produce an image), 2) fluoroscopy (an x-ray variant with dynamic imaging), 3) computerized tomography (“CT”), 4) magnetic resonance imaging (“MRI”), and 5) acoustics/echo.
- X-ray radiation transmitted through a body and received with a sensor to produce an image
- fluoroscopy an x-ray variant with dynamic imaging
- CT computerized tomography
- MRI magnetic resonance imaging
- acoustics/echo acoustics/echo.
- physiological monitoring may include the use of an electrocardiogram, blood pressure monitoring, blood oxygenation sensors, etc.
- electrophysiological applications electrical activity in a designated tissue area, such as the heart, may be monitored or recorded to aid a physician in diagnosing and/or treating a patient.
- electrograms corresponding to underlying physiological mechanisms or morphologies may provide a wealth of information for such diagnoses and treatment.
- Imaging capacity with electrophysiological information in an easily accessible, informative presentation to the physician benefits diagnosis and treatment efforts, and accordingly, there is an ongoing need to provide improvements in both the presentation of such information, as well as processing methodology and correlation to clinically-relevant conditions to provide enhanced information about the characteristics or behavior of a particular treatment or diagnosis site.
- the present invention provides a medical system according to claim 1.
- the present invention advantageously provides systems providing electrophysiological information in an easily accessible, informative presentation to the physician to benefit diagnosis and treatment efforts, as well as processing methodology and correlation to clinically-relevant conditions to provide enhanced information about the characteristics or behavior of a particular treatment or diagnosis site.
- a method of displaying electrophysiological information including obtaining a three-dimensional rendering of an anatomical region; obtaining a monophasic action potential signal; calculating a value associated with a depolarization segment of the monophasic action potential signal; and displaying a graphical indicator of the value on the rendering of the anatomical region.
- the three-dimensional rendering may be generated using electric potential-based navigation, and the electric potential-based navigation may include tracking one or more electrodes in three-dimensional space in proximity to the anatomical region.
- Calculating the value associated with the depolarization segment may include calculating a time duration; calculating an upstroke velocity; calculating a maximum amplitude value; and/or calculating a time duration for the monophasic action potential signal to recede to a predetermined percentage of the maximum amplitude value.
- the method may include identifying a tissue structure based at least in part on the calculated value.
- Obtaining the monophasic action potential signal may include contacting the anatomical region with a medical device and generating a contact status indication based at least in part on the calculated value.
- the method may include obtaining an electrocardiogram signal; comparing at least a portion of the monophasic action potential signal to at least a portion of the electrocardiogram signal; and generating an alert based at least in part on the comparison; for example, comparing at least a portion of the monophasic action potential signal to the electrocardiogram signal may include comparing a portion of the monophasic action potential signal to at least one of a P, QRS, and T-wave portion of the electrocardiogram signal.
- the graphical indicator may include a color assigned to the value, and/or the method may include generating a graphical treatment indicator on the rendering based at least in part on the calculated value, the graphical treatment indicator providing a suggested treatment location.
- a method of mapping electrophysiological information including receiving imaging information for a tissue region; receiving a monophasic action potential signal from the tissue region; assigning a value corresponding to a depolarization segment of the monophasic action potential signal; receiving location information associated with the monophasic action potential signal; and generating an image based on the imaging information, the assigned value, and the location information.
- Receiving imaging information for a tissue region may include acquiring three-dimensional electric potential information.
- Receiving a monophasic action potential signal from the tissue region may include obtaining a monophasic action potential signal with a medical device proximate to the tissue region.
- Receiving location information associated with the monophasic action potential signal may include obtaining location information of the medical device.
- Generating an image may include displaying a three-dimensional rendering of the tissue region, and the rendering may include a color variation indicating the assigned value at a location on the rendering corresponding to the received location information.
- the rendering may also include a color variation indicating a suggested location for treatment.
- a medical system including a display; a control unit in communication with the display, the control unit: receives a monophasic action potential signal, receives three-dimensional location information associated with the monophasic action potential signal, calculates a value corresponding to a depolarization segment of the monophasic action potential signal, and generates an image based on the three-dimensional location information and the calculated value.
- the control unit may: obtain an electrocardiogram signal; compare at least a portion of the monophasic action potential signal to at least a portion of the electrocardiogram signal; and generate an alert based at least in part on the comparison.
- the system may include a medical device in communication with the control unit, the medical device including a plurality of electrodes; and/or an image acquisition device in communication with the control unit.
- US 2011/028820 is an example of a known medical systems for displaying an image of an anatomical region using a monophasic action potential signal of the anatomical region.
- EP1421913 and WO00/42914 disclose known navigation systems for the visualization of catheters during surgical procedures.
- Embodiments of the present invention may provide electrophysiological information in an easily accessible, informative presentation to the physician to benefit diagnosis and treatment efforts, as well as processing methodology and correlation to clinically-relevant conditions to provide enhanced information about the characteristics or behavior of a particular treatment or diagnosis site.
- the system 10 includes a system control/processing unit 12 and one or more devices operable to acquire, measure, monitor or otherwise convey information regarding a patient 14 to the control unit 12 and vice versa.
- the system 10 may include one or more image capture or acquisition devices 16 external to the patient 14 and in communication with the control unit 12.
- image capture and acquisition devices 16 may include an X-ray, fluoroscopic, or computed tomography (“CT") device.
- CT computed tomography
- the image acquisition device(s) 16 may also include, for example, a magnetic resonance imaging (“MRI”) device, an ultrasound/acoustic device, or the like that capture, measure, or otherwise obtain anatomical information (e.g., information regarding a structure of the patient) and/or physiological information (e.g., information regarding processes, functions, conditions, or activities) of the patient 14 for imaging purposes.
- MRI magnetic resonance imaging
- ultrasound/acoustic device or the like that capture, measure, or otherwise obtain anatomical information (e.g., information regarding a structure of the patient) and/or physiological information (e.g., information regarding processes, functions, conditions, or activities) of the patient 14 for imaging purposes.
- the image capture or acquisition devices 16 may also include a three-dimensional electric potential monitoring/recording system, such as the LocaLisa® navigation system from Medtronic, Inc. Action potential information is recorded with respect to an electrode in proximity to or in contact with an anatomical region of interest. The electrode(s) are then moved around in the region of interest while the electric field strength is measured in three different field vectors to create a rendered 3-D surface of the targeted portion of anatomy, such as a heart chamber.
- a three-dimensional electric potential monitoring/recording system such as the LocaLisa® navigation system from Medtronic, Inc.
- Action potential information is recorded with respect to an electrode in proximity to or in contact with an anatomical region of interest.
- the electrode(s) are then moved around in the region of interest while the electric field strength is measured in three different field vectors to create a rendered 3-D surface of the targeted portion of anatomy, such as a heart chamber.
- the system 10 may include one or more physiological assessment devices 18 coupled to or positionable about an exterior of the patient 14 and in communication with the control unit 12.
- the one or more physiological assessment devices 18 generally measures, monitors or records a physiologic state or condition of the patient 14.
- the physiological monitoring device(s) 18 may include one or more electrodes or sensors placed on an exterior of the patient 14 to record an electrogram ("EGM") of electrical activity on or about a portion of the patient 14.
- EMG electrogram
- a specific example of an electrogram may be the recording and/or processing of an electrocardiogram ("ECG”) signal trace using a plurality of electrodes or leads placed on the skin of the patient 14.
- physiological monitoring/measuring device 18 may also be obtained by the physiological monitoring/measuring device 18, including, for example, intracardiac electrograms indicative of an arrhythmia loci, electric potential changes in a particular chamber of the heart or in proximity to the His bundle, esophageal electrograms, or the like.
- physiological assessment devices 18 may include (but are not limited to) blood oxygenation measuring devices, blood pressure measurement devices, blood flow measuring devices (e.g., a device measuring or monitoring flow direction and magnitude, Doppler ultrasound, etc.), temperature monitoring devices, and/or respiration/respiratory rate monitoring devices.'
- the system 10 may include one or more minimally-invasive or interventional medical device(s) 20 positionable within a portion of the patient 14 to acquire anatomical or physiological information, or to otherwise diagnose or treat the patient 14.
- the medical device(s) 20 may be coupled to the control unit 12, which may communicate operational procedures and protocols dictating the operation of the medical device 20 as well as receiving feedback from the medical device 20 regarding the designated procedure, treatment, or the like with respect to the patient 14.
- the medical device(s) 20 may include a catheter having one or more diagnostic or treatment elements that is insertable into the patient 14 through a small incision and routed to a desired region of the patient 14 through a vascular channel, for example.
- the treatment elements on the catheter may include, for example, one or more temperature, pressure, and/or electrical activity sensors facilitating information acquisition, diagnoses, or treatment procedures.
- An example of the medical device 20 may include an endoscope having a video capture assembly on it to obtain images of an internal region of the patient 14.
- Other specific examples of the medical device 20 may include pacing catheters, ablation catheters, or fluid delivery catheters (e.g., to deliver pharmaceutical compounds, imaging contrast fluids, etc.).
- the medical device(s) 20 may be operable to obtain one or more electrograms from an interior of the patient 14, as well as blood pressure, temperature, oxygenation, and the like described above.
- the medical device 20 may include an elongate body or shaft 22 with proximal and distal portions.
- the shaft 22 may be both flexible and resilient, with sufficient column strength facilitating steady contact with tissue to improve signal fidelity in diagnosing contacted tissue as well as improve therapeutic thermal exchange between the device 20 and contacted tissue for particular applications.
- the medical device 20 may further include a handle 24 affixed to the proximal portion of the shaft 22.
- the device 20 may further include a treatment and/or diagnosis assembly 26 coupled to the distal portion of the shaft 22.
- the treatment/diagnosis assembly 26 may include a distal tip or dome housing 28 and an array of electrodes (30a, 30b...collectively referred to as '30') for measuring or detecting electrical activity or signals, such as a monophasic action potential.
- the electrodes 30 may have a partially spherical surface with a relatively small outer diameter, such as outer diameters of about one-half to two millimeters. In one example they may have a diameter of one millimeter. While the first array is illustrated as containing four electrodes, one or more electrodes in any suitable configuration may be implemented.
- the electrodes may be made of one or more non-polarizing materials, such as silver, silver chloride, platinum, iridium, titanium nitride, gold, stainless steel, aluminum, and alloys and combinations thereof for example, to improve the fidelity of detected or monitored signals.
- non-polarizing materials such as silver, silver chloride, platinum, iridium, titanium nitride, gold, stainless steel, aluminum, and alloys and combinations thereof for example, to improve the fidelity of detected or monitored signals.
- the dome housing 28 may be made of various materials, including polymers or metals. If the dome housing 28 is made of a polymer, such as polyether-etherketone (PEEK), polysulfone, polyurethane, acetal, or other similar engineering plastic, it will have an electrically insulating effect to isolate the electrodes 30. Alternately, the dome housing 28 may be made of an electrically conductive material, for example selected from the group consisting of silver, silver chloride, platinum, iridium, gold, stainless steel, aluminum, and alloys and combinations thereof.
- PEEK polyether-etherketone
- the dome housing 28 may be made of an electrically conductive material, for example selected from the group consisting of silver, silver chloride, platinum, iridium, gold, stainless steel, aluminum, and alloys and combinations thereof.
- the medical device 20 may further include an auxiliary electrode 32 on the shaft 22 for determining a potential with relation to a corresponding potential obtained from the electrode array 30.
- the electrode 32 may be positioned a pre-determined distance proximal of the electrode array 30.
- a dedicated pacing electrode 34 may also be included for synchronizing the recorded or monitored signals from the electrode array to a local heartbeat.
- the auxiliary electrode 32 and pacing electrode 34 may have relatively smooth outer surfaces with minimal or no protrusion.
- the auxiliary electrode 32 and pacing electrode 34 may include substantially cylindrical bands surrounding or otherwise attached to the shaft 22 coaxial with a longitudinal axis, for example. These electrodes may be flush with the outer surface of the shaft 22, or may be recessed to reduce a possibility of direct or depolarizing contact with tissue. Alternatively, the auxiliary electrode 30 may be recessed, while the pacing electrode 32 may be larger to increase its exposure and contact with tissue to be paced.
- the medical device may also include features to indicate where at least one component is currently positioned during the phases of a medical treatment. For example, the real-time location of the electrode array 30, as well as the auxiliary electrode 32 and the pacing electrode 34 may be indicated with one or more radiopaque or other trackable markers.
- control/processing unit 12 is coupled to one or more of the image capture or acquisition device(s) 16, physiological assessment devices 18, and/or interventional medical devices 20 described above.
- the control unit 12 may be used to receive and/or process information communicated from the attached devices 16, 18, 20 as well as send operational commands or signals to the devices during their use.
- the control unit 12 may have suitable components for obtaining signals from the attached devices, and may also include one or more sensors to monitor operating parameters throughout the system, including for example, pressure, temperature, flow rates, volume, or similar measurements in the control unit 12 and/or the coupled devices.
- the coupling and communication between the control unit 12 and the devices may be achieved through a direct wired connection or through wireless communication protocols as known in the art.
- the control unit 12 may include one or more controllers, processors, and/or software modules containing instructions or algorithms to provide for the automated operation and performance of the devices, features, sequences, calculations, or procedures described herein.
- the control unit 12 may include electronic storage media 36 retaining information regarding the operation of the control unit 12 and/or the devices 16, 18, 20, including stored anatomical and/or physiological information previously obtained from a patient 14.
- the system 10 may include a display 38 in communication with the control unit 12 to provide visual information regarding the attached devices 16, 18, 20 and/or patient 14, as well as one or more user controls 40 facilitating operation of one or more aspects of the control unit 12 and the devices.
- the display 38 can include, for example, a cathode ray tube ("CRT"), liquid crystal display (“LCD”), or other visual interface generally including a plurality of pixels or segmented display elements for visualizing information from the control unit 12 and/or coupled devices.
- the display 38 may be touch-screen operable and may be removable or releasable from the control unit 12 for ease of use and view. Alternatively, the display 38 may be integrated with the control unit 12 in a portable tablet device.
- the system 10 may further provide for the manipulation of designated images and/or information provided on the display 38.
- the selection, manipulation, processing, and/or visualization of the selected characteristics or configurations of the images and information on the display 38 may be achieved through manipulation of the user controls 40 and the programming/processing components of the control unit 12. Such selective manipulation may include adjusting, rotation, panning, or zooming selected portions of one or more images on the display 38.
- the display 38 may generally include a menu bar 42 indicating available options and other selectable components related to the control unit 12, the display 38, and/or the coupled device(s) 16, 18, 20.
- the display 38 may further include a background 44 as a contrasting backdrop against which other images or information is displayed.
- the display 38 may generally include a first plurality of pixels displaying a first image 46 produced at least in part from information received from one or more of the image acquisition devices 16, the physiological assessment devices 18, and/or the medical devices 20.
- the information resulting in the first image 46 may be acquired from the patient 14 and displayed in substantially real-time and/or displayed from previously-obtained information recalled from the storage media 36 of the control unit 12.
- the first image 46 may include a graphical reproduction or illustration of an anatomical structure or region of the patient 14, such as the heart, and may take up a substantial portion of the display 38 for ease of viewing and reference to an operator.
- the first image 46 may also include one or more medical devices 20 having one or more diagnostic and/or treatment elements 48 (such as those described above) in proximity to the displayed anatomical structure.
- the display 38 may provide multiple images having different viewpoints or orientations of the same anatomical or physiological construct.
- a second image 50 may be displayed with a second plurality of pixels, where the second image 50 is an alternative orientation of the first image 46.
- the first image 46 may include an anterior-posterior view of the illustrated structure, while the second image 50 may include an illustration of the same anatomical structure in a right lateral view.
- other viewpoints may be provided on the display 38, and the display 38 may include a reference indicator or indicia 52 signifying the viewpoint from which the first and second images are shown.
- the display 38 may further include the illustration of a plane of reference 54 to aid a user in recognizing the illustrated orientation of the images at any given time.
- the imaged plane of reference 54 may be, for example, one of the customary sagittal, coronal, and/or transverse anatomical planes and may align with one of the physiological assessment device(s) 18, image capture device(s) 16 or medical device(s) 20.
- the display 38 may also include a third plurality of pixels showing a third image 56 produced at least in part from information received from one or more of the image acquisition devices 16, the physiological assessment devices 18, and/or the medical devices 20.
- the third image 56 may include a graphical reproduction or illustration of one or more values corresponding to a physiological assessment, measurement, or monitored condition.
- the third image 56 may include one or more signal traces or visual indicators corresponding to an ECG, EGM, blood pressure and/or oxygen concentration of the patient 14.
- the third image 56 may include an image or information related to instrumentation use or status.
- the third image 56 may include one or more indications of treatment duration, information regarding expected or actual operational parameters of a one of the image acquisition devices 16, the physiological assessment devices 18, and/or the medical devices 20 (e.g., temperature measurements and thresholds of a device; electrical connection or sensor status and activity of a device, "ON” or “OFF”, etc.).
- the third image 56 may consist of one or more signal traces or indications of the monitored or measured information, including a periodically-updated image or graphic that streams or sweeps across a portion of the display 38 as the information contributing to the third image 56 is updated or acquired.
- the system 10 may be used to process and/or display anatomical and physiological information for a physician.
- information sufficient to generate an image of a targeted tissue site or anatomical region of the patient 14 may be acquired from one or more of the image acquisition devices 16, the physiological assessment devices 18, the medical devices 20, and/or recalled from the storage media 36 of the control unit 12.
- the information may be processed by the control unit 12 to generate, for example, the first and/or second images 46, 50 on the display 38.
- the first and/or second images may include an anatomical structure and/or the positioning of a medical device.
- the system 10 may also generate the third image 56 on the display 38.
- the third image 56 may include physiological and/or instrumentation information.
- the third image 56 may include one or more electrograms monitored or obtained at a designated site of the patient, such as a monophasic action potential ("MAP") signal from a cardiac region of the patient 14.
- MAP monophasic action potential
- a MAP signal may be obtained by placing an electrode, such as one of the electrodes 30 of medical device 20 for example, into contact with a tissue site.
- the medical device can be manipulated to apply local pressure from at least one electrode 30 to the tissue, causing local depolarization to obtain at least one MAP signal, which can be conveyed form the medical device 20 to the control unit 12.
- FIG. 4 an exemplary waveform of a monophasic action potential signal is shown.
- the waveform generally includes a resting potential 58, a depolarization segment 60 and a repolarization segment 62 indicating changes in transmembrane potential of the underlying cells over time due to ion influx and efflux.
- the system 10 receives, processes, and/or calculates a number of parameters or characteristics of an obtained or monitored MAP signal and present such information or indicators based on such information to an operating physician.
- a MAP waveform may generally define a peak voltage amplitude A p and a time duration T Ap taken to reach the peak amplitude A p .
- An associated upstroke velocity V Ap of the depolarization segment may be defined as the peak amplitude A p divided by the time duration T Ap .
- the MAP waveform may also generally define a plateau "P" in the repolarization segment 62, and a difference between the voltage of the peak amplitude A p and the voltage at the plateau "P" may be calculated by the control unit 12. Additional timing and voltage characteristics of an obtained MAP signal may also be measured, processed or calculated by the control unit 12. For example, a total time duration T t extending from the initial depolarization and a return to baseline or resting potential may be calculated or measured.
- the timing associated with a voltage decay or drop as a percentage of the peak amplitude A p may also be measured or calculated, e.g., the time it takes for the voltage to drop to 90% of the peak amplitude A p - T 90 , or for other selected voltage percentage decreases - T % .
- a refractory period or time duration between subsequent MAP signals or waveforms may be calculated, i.e., the time period between a repolarization segment reaching the resting potential and a following depolarization segment.
- the control unit 12 processes, calculates, or otherwise measure a plurality of such MAP signal metrics and provide an indication of abnormal tissue morphology, specific anatomical structures or physiological functions, as well as provide a basis for assessing contact status and other operating parameters of the system 10.
- FIG. 5 illustrates a plurality of signals including an electrocardiogram 63 and two electrogram signals 64, 66.
- Both electrogram signals 64, 66 indicate a depolarization segment or spike, but no plateau or other MAP signal characteristics (which the control unit 12 could analyze and conclude through an assessment of a difference between the voltage of the peak amplitude A p and the voltage at the plateau "P", or through calculating the total time duration T t extending from the initial depolarization and a return to baseline, for example, as compared to expected or predefined threshold values).
- the tissue site may include inactive myocardial cells constituting scar tissue or ablated tissue, or that the contact between the medical device 20 and the tissue site is insufficient.
- control unit 12 may generate an alert to reposition the device or verify contact through imaging means, and/or visually designate the particular tissue region on the display with the concluded morphology resulting from the analysis of the MAP signal, as discussed in more detail below.
- the control unit 12 may receive a plurality of MAP signals from one or more sources and, based on the analysis and processing of the parameters described herein, select one signal over another to show on the display 38 for an operator or physician, while additionally or alternatively generating an alert that the source or device obtaining the second signal 66 should be repositioned.
- the first and second signals 64, 66 initially display qualitative MAP characteristics, yet deteriorate into a different signal appearance.
- the control unit 12 may continuously assess the MAP signal parameters and generate an alert that sufficient contact with the tissue has been lost should any such change in signal occur.
- MAP signal characteristics may also be used to differentiate tissue structures. For example, MAP signals obtained from pacemaker cells such as the sinus node differ from the MAP signals of conduction and myocardial cells. Whereas calcium is the main electrolyte responsible for pacemaker cell depolarization, sodium and potassium are the main electrolytes responsible for depolarization of myocardial cells and cells dedicated to conduction of impulses.
- the control unit 12 also compares one or more MAP signals or characteristics thereof to an electrocardiogram signal to assess or verify the quality of the signal information received.
- the timing of a MAP signal or waveform are compared to a P, QRS, and/or T-wave segment of a surface electrogram or electrocardiogram.
- the extent that a repolarization segment of a MAP signal coincides with the repolarization indication of the T-wave of an electrocardiogram can be used to assess the quality of a MAP signal.
- the processed or computed metrics of an obtained MAP signal may be compared to expected or predetermined baseline or threshold values, or may be compared to surrounding population values or measurements taken within a designated tissue area. Differences between obtained MAP signal metrics and expected or surrounding values or measurements may be graphically displayed by the system 10 to graphically indicate or map abnormally-behaving regions (which may indicate underlying ion channel irregularities, for example) to aid in diagnosis or treatment. Such ion channel irregularities may include, for example, long QT syndrome (which may be indicated by an extended plateau on a MAP signal exceeding a designated threshold) or Burgada syndrome (which may be indicated by a "saddlebag” or dip in the plateau of the MAP signal).
- the graphical indication may include spatial and/or temporal presentations to indicate characteristics across a plurality of locations, or metrics and analysis for a substantially single location over time, respectively.
- the first and second images 46, 50 may include an anatomical rendering of a tissue region or structure of the patient 14.
- Information resulting from the analysis of the MAP signal metrics may be graphically overlaid or integrated into the first and/or second images 46, 50 at a location on the images corresponding to the location where the MAP signal was taken in the patient, and may also include a time stamp or other temporal indication.
- the location information of the MAP signal may be obtained through tracking the medical device 20, for example, used to record or otherwise obtain the MAP signal. Location or position information regarding the medical device 20, and thus the MAP signal, may be obtained through medical device tracking systems and methodologies as known in the art.
- the calculated or processed values of the MAP signal characteristics may be assigned or correlated to a graphical indicator to emphasize differences in measured or processed values from expected values on the display 38.
- FIG. 8 illustrates a color scheme that can be used to graphically distinguish variations from an expected value (e.g., 0,0) along two different axes.
- the axes may represent variations in voltage and time, respectively.
- These color variations can then be shown on segments 68 of the first and/or second images that have been mapped with electrophysiological readings or measurements.
- the mapped segment 68 graphically shows areas or sectors having deviations from expected values directly on the anatomical rendering, while values or metrics of MAP signals that are within expected ranges are shown as a base color.
- the mapped segment 68 is shown in a substantially planar form in FIG. 9 for reference.
- the calculated values and/or deviations may be assigned to graphical indicators on a spatial or temporal basis.
- a mapped, displayed region may indicate different values (i.e., different colors) from one location to the next, or may include assigned graphical indicators or colors based on a deviation or change in a measured value form a single location over time (i.e., a base color indicates little change over time, while another color or marker indicates significant change over time).
- the system 10 may also provide a visual or graphic indication suggesting or recommending locations for treatment or further action based at least in part on the measured and/or processed metrics of the MAP signal.
- the control unit 14 and/or display could generate a "flag" or "hot spot” indication (in addition to the graphical indicator representing the measured deviation) for further action.
- the criteria for generating such an alert or visual marker on the display could include an analysis of one or more of the measured MAP characteristics as compared to clinically expected values or patient-specific data.
- a threshold for generating such an alert may include, for example, that at least three metrics of the MAP signal exceed expected values (i.e., upstroke velocity, plateau duration, maximum voltage, etc.).
- the mapped segment is shown in FIG. 3 as a portion of the first image 46, it is contemplated that an entire anatomical region and its associated imaged rendering may be mapped for electrophysiological activity and MAP metrics.
- the maped segment 68 is shown as including a plurality of square-like sectors, it is contemplated that the rendered image may be divided into a myriad of different groupings to indicate the desired MAP signal parameters or assigned values.
- a three-dimensional rendering may include a plurality of triangles intersecting at vertices indicating changes in the tissue topography, with the resulting electrophysiological assessment being assigned or attributed to an individual triangle on an image.
- data may be mapped to any map including, but not limited to, a two- or three-dimensional, static or time-varying image or model.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Cardiology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Description
- The present invention relates generally to medical systems, and more particularly to obtaining, processing and displaying electrophysiological information for clinical use.
- In modern medicine, a considerable number of interventional procedures have been developed and typically require physiologic monitoring of a patient using various imaging techniques and diagnostic instrumentation. Indeed, image guided procedures employing visual displays to guide and assist a physician operator are commonplace in the interventional laboratories and operating theaters. A variety of instrumentation modalities provide images to guide interventional procedures. In some situations, images are acquired prior to the interventional procedure or treatment. Other approaches involve acquiring images at the beginning of the procedure, while still some other procedures involve the acquisition of data in real-time.
- Commonly used instrumentation modalities used to image patient anatomy and physiology include 1) X-ray (radiation transmitted through a body and received with a sensor to produce an image), 2) fluoroscopy (an x-ray variant with dynamic imaging), 3) computerized tomography ("CT"), 4) magnetic resonance imaging ("MRI"), and 5) acoustics/echo.
- In addition to imaging, various physiological parameters are often monitored during an interventional procedure. For example, such physiological monitoring may include the use of an electrocardiogram, blood pressure monitoring, blood oxygenation sensors, etc. For electrophysiological applications, electrical activity in a designated tissue area, such as the heart, may be monitored or recorded to aid a physician in diagnosing and/or treating a patient. Such electrograms corresponding to underlying physiological mechanisms or morphologies may provide a wealth of information for such diagnoses and treatment.
- Combining imaging capacity with electrophysiological information in an easily accessible, informative presentation to the physician benefits diagnosis and treatment efforts, and accordingly, there is an ongoing need to provide improvements in both the presentation of such information, as well as processing methodology and correlation to clinically-relevant conditions to provide enhanced information about the characteristics or behavior of a particular treatment or diagnosis site.
- The present invention provides a medical system according to claim 1. The present invention advantageously provides systems providing electrophysiological information in an easily accessible, informative presentation to the physician to benefit diagnosis and treatment efforts, as well as processing methodology and correlation to clinically-relevant conditions to provide enhanced information about the characteristics or behavior of a particular treatment or diagnosis site.
- In particular, a method of displaying electrophysiological information is disclosed, not forming part of the current invention, including obtaining a three-dimensional rendering of an anatomical region; obtaining a monophasic action potential signal; calculating a value associated with a depolarization segment of the monophasic action potential signal; and displaying a graphical indicator of the value on the rendering of the anatomical region. The three-dimensional rendering may be generated using electric potential-based navigation, and the electric potential-based navigation may include tracking one or more electrodes in three-dimensional space in proximity to the anatomical region. Calculating the value associated with the depolarization segment may include calculating a time duration; calculating an upstroke velocity; calculating a maximum amplitude value; and/or calculating a time duration for the monophasic action potential signal to recede to a predetermined percentage of the maximum amplitude value. The method may include identifying a tissue structure based at least in part on the calculated value. Obtaining the monophasic action potential signal may include contacting the anatomical region with a medical device and generating a contact status indication based at least in part on the calculated value. The method may include obtaining an electrocardiogram signal; comparing at least a portion of the monophasic action potential signal to at least a portion of the electrocardiogram signal; and generating an alert based at least in part on the comparison; for example, comparing at least a portion of the monophasic action potential signal to the electrocardiogram signal may include comparing a portion of the monophasic action potential signal to at least one of a P, QRS, and T-wave portion of the electrocardiogram signal. The graphical indicator may include a color assigned to the value, and/or the method may include generating a graphical treatment indicator on the rendering based at least in part on the calculated value, the graphical treatment indicator providing a suggested treatment location.
- A method of mapping electrophysiological information is disclosed, not forming part of the current invention, including receiving imaging information for a tissue region; receiving a monophasic action potential signal from the tissue region; assigning a value corresponding to a depolarization segment of the monophasic action potential signal; receiving location information associated with the monophasic action potential signal; and generating an image based on the imaging information, the assigned value, and the location information. Receiving imaging information for a tissue region may include acquiring three-dimensional electric potential information. Receiving a monophasic action potential signal from the tissue region may include obtaining a monophasic action potential signal with a medical device proximate to the tissue region. Receiving location information associated with the monophasic action potential signal may include obtaining location information of the medical device. Generating an image may include displaying a three-dimensional rendering of the tissue region, and the rendering may include a color variation indicating the assigned value at a location on the rendering corresponding to the received location information. The rendering may also include a color variation indicating a suggested location for treatment.
- A medical system is disclosed, including a display; a control unit in communication with the display, the control unit: receives a monophasic action potential signal, receives three-dimensional location information associated with the monophasic action potential signal, calculates a value corresponding to a depolarization segment of the monophasic action potential signal, and generates an image based on the three-dimensional location information and the calculated value. The control unit may: obtain an electrocardiogram signal; compare at least a portion of the monophasic action potential signal to at least a portion of the electrocardiogram signal; and generate an alert based at least in part on the comparison. The system may include a medical device in communication with the control unit, the medical device including a plurality of electrodes; and/or an image acquisition device in communication with the control unit.
US 2011/028820 is an example of a known medical systems for displaying an image of an anatomical region using a monophasic action potential signal of the anatomical region.EP1421913 andWO00/42914 - A more complete understanding of the present invention, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
-
FIG. 1 is an illustration of an example of a medical system constructed in accordance with the principles of the present invention; -
FIG. 2 is an additional illustration of the system inFIG. 1 ; -
FIG. 3 is an illustration of an example of an image display of the system ofFIG. 1 ; -
FIG. 4 is a diagram of an example of a monophasic action potential electrogram; -
FIG. 5 is an illustration of a plurality of exemplary waveforms for use with the system ofFIG. 1 ; -
FIG. 6 is another illustration of a plurality of exemplary waveforms for use with the system ofFIG. 1 ; -
FIG. 7 is still another illustration of a plurality of exemplary waveforms for use with the system ofFIG. 1 ; -
FIG. 8 is an illustration of a graphical identification scheme for a plurality of measured values; and -
FIG. 9 is an illustration of an image including electrophysiological indicators. - Embodiments of the present invention may provide electrophysiological information in an easily accessible, informative presentation to the physician to benefit diagnosis and treatment efforts, as well as processing methodology and correlation to clinically-relevant conditions to provide enhanced information about the characteristics or behavior of a particular treatment or diagnosis site. Now referring to the drawings in which like reference designators refer to like elements there is shown in
FIG. 1 an embodiment of a medical system referred to generally as "10." Thesystem 10 includes a system control/processing unit 12 and one or more devices operable to acquire, measure, monitor or otherwise convey information regarding apatient 14 to thecontrol unit 12 and vice versa. - For example, the
system 10 may include one or more image capture oracquisition devices 16 external to thepatient 14 and in communication with thecontrol unit 12. Examples of such image capture andacquisition devices 16 may include an X-ray, fluoroscopic, or computed tomography ("CT") device. The image acquisition device(s) 16 may also include, for example, a magnetic resonance imaging ("MRI") device, an ultrasound/acoustic device, or the like that capture, measure, or otherwise obtain anatomical information (e.g., information regarding a structure of the patient) and/or physiological information (e.g., information regarding processes, functions, conditions, or activities) of thepatient 14 for imaging purposes. The image capture oracquisition devices 16 may also include a three-dimensional electric potential monitoring/recording system, such as the LocaLisa® navigation system from Medtronic, Inc. Action potential information is recorded with respect to an electrode in proximity to or in contact with an anatomical region of interest. The electrode(s) are then moved around in the region of interest while the electric field strength is measured in three different field vectors to create a rendered 3-D surface of the targeted portion of anatomy, such as a heart chamber. - The
system 10 may include one or morephysiological assessment devices 18 coupled to or positionable about an exterior of thepatient 14 and in communication with thecontrol unit 12. The one or morephysiological assessment devices 18 generally measures, monitors or records a physiologic state or condition of thepatient 14. For example, the physiological monitoring device(s) 18 may include one or more electrodes or sensors placed on an exterior of thepatient 14 to record an electrogram ("EGM") of electrical activity on or about a portion of thepatient 14. As used herein, the term electrogram is referred to as a recording or measurement of changes in electric potential. A specific example of an electrogram may be the recording and/or processing of an electrocardiogram ("ECG") signal trace using a plurality of electrodes or leads placed on the skin of thepatient 14. Various other electrograms may also be obtained by the physiological monitoring/measuring device 18, including, for example, intracardiac electrograms indicative of an arrhythmia loci, electric potential changes in a particular chamber of the heart or in proximity to the His bundle, esophageal electrograms, or the like. Other examples ofphysiological assessment devices 18 may include (but are not limited to) blood oxygenation measuring devices, blood pressure measurement devices, blood flow measuring devices (e.g., a device measuring or monitoring flow direction and magnitude, Doppler ultrasound, etc.), temperature monitoring devices, and/or respiration/respiratory rate monitoring devices.' - The
system 10 may include one or more minimally-invasive or interventional medical device(s) 20 positionable within a portion of thepatient 14 to acquire anatomical or physiological information, or to otherwise diagnose or treat thepatient 14. The medical device(s) 20 may be coupled to thecontrol unit 12, which may communicate operational procedures and protocols dictating the operation of themedical device 20 as well as receiving feedback from themedical device 20 regarding the designated procedure, treatment, or the like with respect to thepatient 14. The medical device(s) 20 may include a catheter having one or more diagnostic or treatment elements that is insertable into the patient 14 through a small incision and routed to a desired region of the patient 14 through a vascular channel, for example. The treatment elements on the catheter may include, for example, one or more temperature, pressure, and/or electrical activity sensors facilitating information acquisition, diagnoses, or treatment procedures. An example of themedical device 20 may include an endoscope having a video capture assembly on it to obtain images of an internal region of thepatient 14. Other specific examples of themedical device 20 may include pacing catheters, ablation catheters, or fluid delivery catheters (e.g., to deliver pharmaceutical compounds, imaging contrast fluids, etc.). The medical device(s) 20 may be operable to obtain one or more electrograms from an interior of thepatient 14, as well as blood pressure, temperature, oxygenation, and the like described above. - Referring now to
FIG. 2 , a particular example of themedical device 20 is shown. Themedical device 20 may include an elongate body orshaft 22 with proximal and distal portions. Theshaft 22 may be both flexible and resilient, with sufficient column strength facilitating steady contact with tissue to improve signal fidelity in diagnosing contacted tissue as well as improve therapeutic thermal exchange between thedevice 20 and contacted tissue for particular applications. Themedical device 20 may further include ahandle 24 affixed to the proximal portion of theshaft 22. - The
device 20 may further include a treatment and/ordiagnosis assembly 26 coupled to the distal portion of theshaft 22. The treatment/diagnosis assembly 26 may include a distal tip ordome housing 28 and an array of electrodes (30a, 30b...collectively referred to as '30') for measuring or detecting electrical activity or signals, such as a monophasic action potential. The electrodes 30 may have a partially spherical surface with a relatively small outer diameter, such as outer diameters of about one-half to two millimeters. In one example they may have a diameter of one millimeter. While the first array is illustrated as containing four electrodes, one or more electrodes in any suitable configuration may be implemented. The electrodes may be made of one or more non-polarizing materials, such as silver, silver chloride, platinum, iridium, titanium nitride, gold, stainless steel, aluminum, and alloys and combinations thereof for example, to improve the fidelity of detected or monitored signals. - The
dome housing 28 may be made of various materials, including polymers or metals. If thedome housing 28 is made of a polymer, such as polyether-etherketone (PEEK), polysulfone, polyurethane, acetal, or other similar engineering plastic, it will have an electrically insulating effect to isolate the electrodes 30. Alternately, thedome housing 28 may be made of an electrically conductive material, for example selected from the group consisting of silver, silver chloride, platinum, iridium, gold, stainless steel, aluminum, and alloys and combinations thereof. If thedome housing 28 is made of metal, an insulating material such as one or more polymers may be provided between thedome housing 28 and the electrodes 30, and thedome housing 28 may further serve as a conduit for the delivery of radiofrequency ablation energy. Themedical device 20 may further include anauxiliary electrode 32 on theshaft 22 for determining a potential with relation to a corresponding potential obtained from the electrode array 30. Theelectrode 32 may be positioned a pre-determined distance proximal of the electrode array 30. Adedicated pacing electrode 34 may also be included for synchronizing the recorded or monitored signals from the electrode array to a local heartbeat. Theauxiliary electrode 32 and pacingelectrode 34 may have relatively smooth outer surfaces with minimal or no protrusion. Theauxiliary electrode 32 and pacingelectrode 34 may include substantially cylindrical bands surrounding or otherwise attached to theshaft 22 coaxial with a longitudinal axis, for example. These electrodes may be flush with the outer surface of theshaft 22, or may be recessed to reduce a possibility of direct or depolarizing contact with tissue. Alternatively, the auxiliary electrode 30 may be recessed, while the pacingelectrode 32 may be larger to increase its exposure and contact with tissue to be paced.
The medical device may also include features to indicate where at least one component is currently positioned during the phases of a medical treatment. For example, the real-time location of the electrode array 30, as well as theauxiliary electrode 32 and the pacingelectrode 34 may be indicated with one or more radiopaque or other trackable markers. - Referring again to
FIG. 1 , the control/processing unit 12 is coupled to one or more of the image capture or acquisition device(s) 16,physiological assessment devices 18, and/or interventionalmedical devices 20 described above. Thecontrol unit 12 may be used to receive and/or process information communicated from the attacheddevices control unit 12 may have suitable components for obtaining signals from the attached devices, and may also include one or more sensors to monitor operating parameters throughout the system, including for example, pressure, temperature, flow rates, volume, or similar measurements in thecontrol unit 12 and/or the coupled devices. - The coupling and communication between the
control unit 12 and the devices may be achieved through a direct wired connection or through wireless communication protocols as known in the art. Thecontrol unit 12 may include one or more controllers, processors, and/or software modules containing instructions or algorithms to provide for the automated operation and performance of the devices, features, sequences, calculations, or procedures described herein. Thecontrol unit 12 may includeelectronic storage media 36 retaining information regarding the operation of thecontrol unit 12 and/or thedevices patient 14. - The
system 10 may include adisplay 38 in communication with thecontrol unit 12 to provide visual information regarding the attacheddevices patient 14, as well as one or more user controls 40 facilitating operation of one or more aspects of thecontrol unit 12 and the devices. Thedisplay 38 can include, for example, a cathode ray tube ("CRT"), liquid crystal display ("LCD"), or other visual interface generally including a plurality of pixels or segmented display elements for visualizing information from thecontrol unit 12 and/or coupled devices. Thedisplay 38 may be touch-screen operable and may be removable or releasable from thecontrol unit 12 for ease of use and view. Alternatively, thedisplay 38 may be integrated with thecontrol unit 12 in a portable tablet device. - The
system 10 may further provide for the manipulation of designated images and/or information provided on thedisplay 38. The selection, manipulation, processing, and/or visualization of the selected characteristics or configurations of the images and information on thedisplay 38 may be achieved through manipulation of the user controls 40 and the programming/processing components of thecontrol unit 12. Such selective manipulation may include adjusting, rotation, panning, or zooming selected portions of one or more images on thedisplay 38. - Now referring to
FIG. 3 , an exemplary visual presentation of medical information on thedisplay 38 is shown. Thedisplay 38 may generally include amenu bar 42 indicating available options and other selectable components related to thecontrol unit 12, thedisplay 38, and/or the coupled device(s) 16, 18, 20. Thedisplay 38 may further include abackground 44 as a contrasting backdrop against which other images or information is displayed. - The
display 38 may generally include a first plurality of pixels displaying afirst image 46 produced at least in part from information received from one or more of theimage acquisition devices 16, thephysiological assessment devices 18, and/or themedical devices 20. The information resulting in thefirst image 46 may be acquired from thepatient 14 and displayed in substantially real-time and/or displayed from previously-obtained information recalled from thestorage media 36 of thecontrol unit 12. Thefirst image 46 may include a graphical reproduction or illustration of an anatomical structure or region of thepatient 14, such as the heart, and may take up a substantial portion of thedisplay 38 for ease of viewing and reference to an operator. Thefirst image 46 may also include one or moremedical devices 20 having one or more diagnostic and/or treatment elements 48 (such as those described above) in proximity to the displayed anatomical structure. - The
display 38 may provide multiple images having different viewpoints or orientations of the same anatomical or physiological construct. For example, asecond image 50 may be displayed with a second plurality of pixels, where thesecond image 50 is an alternative orientation of thefirst image 46. As shown inFIG. 3 , thefirst image 46 may include an anterior-posterior view of the illustrated structure, while thesecond image 50 may include an illustration of the same anatomical structure in a right lateral view. Of course, other viewpoints may be provided on thedisplay 38, and thedisplay 38 may include a reference indicator orindicia 52 signifying the viewpoint from which the first and second images are shown. Thedisplay 38 may further include the illustration of a plane ofreference 54 to aid a user in recognizing the illustrated orientation of the images at any given time. The imaged plane ofreference 54 may be, for example, one of the customary sagittal, coronal, and/or transverse anatomical planes and may align with one of the physiological assessment device(s) 18, image capture device(s) 16 or medical device(s) 20. - The
display 38 may also include a third plurality of pixels showing athird image 56 produced at least in part from information received from one or more of theimage acquisition devices 16, thephysiological assessment devices 18, and/or themedical devices 20. Thethird image 56 may include a graphical reproduction or illustration of one or more values corresponding to a physiological assessment, measurement, or monitored condition. For example, thethird image 56 may include one or more signal traces or visual indicators corresponding to an ECG, EGM, blood pressure and/or oxygen concentration of thepatient 14. Thethird image 56 may include an image or information related to instrumentation use or status. For example, thethird image 56 may include one or more indications of treatment duration, information regarding expected or actual operational parameters of a one of theimage acquisition devices 16, thephysiological assessment devices 18, and/or the medical devices 20 (e.g., temperature measurements and thresholds of a device; electrical connection or sensor status and activity of a device, "ON" or "OFF", etc.). Thethird image 56 may consist of one or more signal traces or indications of the monitored or measured information, including a periodically-updated image or graphic that streams or sweeps across a portion of thedisplay 38 as the information contributing to thethird image 56 is updated or acquired. - The
system 10 may be used to process and/or display anatomical and physiological information for a physician. Primarily, information sufficient to generate an image of a targeted tissue site or anatomical region of the patient 14 may be acquired from one or more of theimage acquisition devices 16, thephysiological assessment devices 18, themedical devices 20, and/or recalled from thestorage media 36 of thecontrol unit 12. Once the imaging information has been acquired or loaded from storage, the information may be processed by thecontrol unit 12 to generate, for example, the first and/orsecond images display 38. As described above, the first and/or second images may include an anatomical structure and/or the positioning of a medical device. Thesystem 10 may also generate thethird image 56 on thedisplay 38. - As described above, the
third image 56 may include physiological and/or instrumentation information. Thethird image 56 may include one or more electrograms monitored or obtained at a designated site of the patient, such as a monophasic action potential ("MAP") signal from a cardiac region of thepatient 14. A MAP signal may be obtained by placing an electrode, such as one of the electrodes 30 ofmedical device 20 for example, into contact with a tissue site. The medical device can be manipulated to apply local pressure from at least one electrode 30 to the tissue, causing local depolarization to obtain at least one MAP signal, which can be conveyed form themedical device 20 to thecontrol unit 12. - Turning to
FIG. 4 , an exemplary waveform of a monophasic action potential signal is shown. The waveform generally includes a restingpotential 58, adepolarization segment 60 and arepolarization segment 62 indicating changes in transmembrane potential of the underlying cells over time due to ion influx and efflux. Thesystem 10 receives, processes, and/or calculates a number of parameters or characteristics of an obtained or monitored MAP signal and present such information or indicators based on such information to an operating physician. For example, a MAP waveform may generally define a peak voltage amplitude Ap and a time duration TAp taken to reach the peak amplitude Ap. An associated upstroke velocity VAp of the depolarization segment may be defined as the peak amplitude Ap divided by the time duration TAp. The MAP waveform may also generally define a plateau "P" in therepolarization segment 62, and a difference between the voltage of the peak amplitude Ap and the voltage at the plateau "P" may be calculated by thecontrol unit 12. Additional timing and voltage characteristics of an obtained MAP signal may also be measured, processed or calculated by thecontrol unit 12. For example, a total time duration Tt extending from the initial depolarization and a return to baseline or resting potential may be calculated or measured. The timing associated with a voltage decay or drop as a percentage of the peak amplitude Ap may also be measured or calculated, e.g., the time it takes for the voltage to drop to 90% of the peak amplitude Ap- T90, or for other selected voltage percentage decreases - T%. Further, a refractory period or time duration between subsequent MAP signals or waveforms may be calculated, i.e., the time period between a repolarization segment reaching the resting potential and a following depolarization segment. - The
control unit 12 processes, calculates, or otherwise measure a plurality of such MAP signal metrics and provide an indication of abnormal tissue morphology, specific anatomical structures or physiological functions, as well as provide a basis for assessing contact status and other operating parameters of thesystem 10. For example,FIG. 5 illustrates a plurality of signals including anelectrocardiogram 63 and twoelectrogram signals control unit 12 could analyze and conclude through an assessment of a difference between the voltage of the peak amplitude Ap and the voltage at the plateau "P", or through calculating the total time duration Tt extending from the initial depolarization and a return to baseline, for example, as compared to expected or predefined threshold values). These characteristics suggest that the tissue site may include inactive myocardial cells constituting scar tissue or ablated tissue, or that the contact between themedical device 20 and the tissue site is insufficient. Based on processing the parameters above, thecontrol unit 12 may generate an alert to reposition the device or verify contact through imaging means, and/or visually designate the particular tissue region on the display with the concluded morphology resulting from the analysis of the MAP signal, as discussed in more detail below. - Turning to
FIG. 6 , two signals are shown, where thefirst signal 64 includes greater MAP characteristics than asecond signal 66. Thecontrol unit 12 may receive a plurality of MAP signals from one or more sources and, based on the analysis and processing of the parameters described herein, select one signal over another to show on thedisplay 38 for an operator or physician, while additionally or alternatively generating an alert that the source or device obtaining thesecond signal 66 should be repositioned. InFIG. 7 , the first andsecond signals control unit 12 may continuously assess the MAP signal parameters and generate an alert that sufficient contact with the tissue has been lost should any such change in signal occur. - MAP signal characteristics may also be used to differentiate tissue structures. For example, MAP signals obtained from pacemaker cells such as the sinus node differ from the MAP signals of conduction and myocardial cells. Whereas calcium is the main electrolyte responsible for pacemaker cell depolarization, sodium and potassium are the main electrolytes responsible for depolarization of myocardial cells and cells dedicated to conduction of impulses.
- The
control unit 12 also compares one or more MAP signals or characteristics thereof to an electrocardiogram signal to assess or verify the quality of the signal information received. In particular, the timing of a MAP signal or waveform are compared to a P, QRS, and/or T-wave segment of a surface electrogram or electrocardiogram. For example, the extent that a repolarization segment of a MAP signal coincides with the repolarization indication of the T-wave of an electrocardiogram can be used to assess the quality of a MAP signal. - The processed or computed metrics of an obtained MAP signal may be compared to expected or predetermined baseline or threshold values, or may be compared to surrounding population values or measurements taken within a designated tissue area. Differences between obtained MAP signal metrics and expected or surrounding values or measurements may be graphically displayed by the
system 10 to graphically indicate or map abnormally-behaving regions (which may indicate underlying ion channel irregularities, for example) to aid in diagnosis or treatment. Such ion channel irregularities may include, for example, long QT syndrome (which may be indicated by an extended plateau on a MAP signal exceeding a designated threshold) or Burgada syndrome (which may be indicated by a "saddlebag" or dip in the plateau of the MAP signal). - The graphical indication may include spatial and/or temporal presentations to indicate characteristics across a plurality of locations, or metrics and analysis for a substantially single location over time, respectively. For example, referring again to
FIG. 3 , the first andsecond images patient 14. Information resulting from the analysis of the MAP signal metrics may be graphically overlaid or integrated into the first and/orsecond images medical device 20, for example, used to record or otherwise obtain the MAP signal. Location or position information regarding themedical device 20, and thus the MAP signal, may be obtained through medical device tracking systems and methodologies as known in the art. - The calculated or processed values of the MAP signal characteristics may be assigned or correlated to a graphical indicator to emphasize differences in measured or processed values from expected values on the
display 38. For example,FIG. 8 illustrates a color scheme that can be used to graphically distinguish variations from an expected value (e.g., 0,0) along two different axes. For MAP signal values, the axes may represent variations in voltage and time, respectively. These color variations can then be shown onsegments 68 of the first and/or second images that have been mapped with electrophysiological readings or measurements. As shown inFIG. 3 , the mappedsegment 68 graphically shows areas or sectors having deviations from expected values directly on the anatomical rendering, while values or metrics of MAP signals that are within expected ranges are shown as a base color. The mappedsegment 68 is shown in a substantially planar form inFIG. 9 for reference. The calculated values and/or deviations may be assigned to graphical indicators on a spatial or temporal basis. For example, a mapped, displayed region may indicate different values (i.e., different colors) from one location to the next, or may include assigned graphical indicators or colors based on a deviation or change in a measured value form a single location over time (i.e., a base color indicates little change over time, while another color or marker indicates significant change over time). - The
system 10 may also provide a visual or graphic indication suggesting or recommending locations for treatment or further action based at least in part on the measured and/or processed metrics of the MAP signal. For example, should the MAP single analysis include a plurality of metrics or characteristics deviating from the expected values, thecontrol unit 14 and/or display could generate a "flag" or "hot spot" indication (in addition to the graphical indicator representing the measured deviation) for further action. The criteria for generating such an alert or visual marker on the display could include an analysis of one or more of the measured MAP characteristics as compared to clinically expected values or patient-specific data. A threshold for generating such an alert may include, for example, that at least three metrics of the MAP signal exceed expected values (i.e., upstroke velocity, plateau duration, maximum voltage, etc.). - Though the mapped segment is shown in
FIG. 3 as a portion of thefirst image 46, it is contemplated that an entire anatomical region and its associated imaged rendering may be mapped for electrophysiological activity and MAP metrics. In addition, though themaped segment 68 is shown as including a plurality of square-like sectors, it is contemplated that the rendered image may be divided into a myriad of different groupings to indicate the desired MAP signal parameters or assigned values. For example, a three-dimensional rendering may include a plurality of triangles intersecting at vertices indicating changes in the tissue topography, with the resulting electrophysiological assessment being assigned or attributed to an individual triangle on an image. Further, while the description above describes data being mapped to a three-dimensional model, data may be mapped to any map including, but not limited to, a two- or three-dimensional, static or time-varying image or model. - It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described herein above. In addition, unless mention was made above to the contrary, it should be noted that all of the accompanying drawings are not to scale. A variety of modifications and variations are possible in light of the above teachings without departing from the scope of the invention, which is limited only by the following claims.
Claims (12)
- A medical system (10), comprising:a display (38);a control unit (12) in communication with the display (38), the control unit (12) programmed to:receive a monophasic action potential signal of an anatomical region, characterized in that the control unit is further programmed to: receive three-dimensional location information associated with the monophasic action potential signal;receive an electrocardiogram signal;calculate a value corresponding to a depolarization segment of the monophasic action potential signal based upon at least one from the group consisting of:a calculation of a time duration;a calculation of an upstroke velocity;a calculation of a maximum amplitude value; anda calculation of a time duration for the monophasic action potential signal to recede to a predetermined percentage of the maximum amplitude value;generate an image of the anatomical region based on the three-dimensional location information and the calculated value; andcompare at least one of a timing and a waveform of the monophasic action potential signal to at least one of a P-wave segment, a QRS complex, and T-wave segment of the electrocardiogram signal and assess the quality of the monophasic action potential signal based on the comparison.
- The system (10) of Claim 1, further comprising a medical device (20) in communication with the control unit (12), the medical device including a plurality of electrodes (30).
- The system (10) of claim 1, further comprising an image acquisition device (16) in communication with the control unit (12).
- The system (10) of claim 1, wherein the image is generated using electric potential-based navigation.
- The system (10) of claim 4, wherein the electric potential-based navigation includes tracking one or more of the plurality of electrodes in three-dimensional space in proximity to the anatomical region.
- The system (10) of claim 1, wherein the control unit (12) identifies a tissue structure based at least in part on the calculated value.
- The system (10) of claim 2, wherein the monophasic action potential signal is generated by the medical device (20) being placed in contact with the anatomical region, the control unit (12) generating a contact status indication based at least in part on the calculated value.
- The system (10) of claim 1, wherein the comparison between the timing or the waveform of the monophasic action potential signal and the at least one of the P-wave segment, the QRS complex, and the T-Wave segment of the electrocardiogram signal includes a comparison between a repolarization segment of the monophasic action potential signal and a repolarization indication of the T-wave portion of the electrocardiogram signal.
- The system (10) of Claim 1, wherein the control unit (12) displays a graphical indicator of the value on the image.
- The system (10) of claim 9, wherein the graphical indicator includes a color assigned to the value.
- The system (10) of claim 1, wherein the image is of an anatomical region and the anatomical region includes at least a portion of a heart.
- The system (10) of claim 1, wherein the control unit (12) generates a graphical treatment indicator on the image based at least in part on the calculated value, the graphical treatment indicator providing a recommended treatment location.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/084,853 US10039502B2 (en) | 2011-04-12 | 2011-04-12 | Electrophysiological signal processing and utilization |
PCT/US2012/033171 WO2012142197A1 (en) | 2011-04-12 | 2012-04-12 | Electrophysiological signal processing and utilization of a monophasic action potential |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2696753A1 EP2696753A1 (en) | 2014-02-19 |
EP2696753B1 true EP2696753B1 (en) | 2021-09-15 |
Family
ID=45998677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12716167.7A Active EP2696753B1 (en) | 2011-04-12 | 2012-04-12 | System for ELECTROPHYSIOLOGICAL SIGNAL PROCESSING AND UTILIZATION OF A MONOPHASIC ACTION POTENTIAL |
Country Status (4)
Country | Link |
---|---|
US (1) | US10039502B2 (en) |
EP (1) | EP2696753B1 (en) |
CN (1) | CN103648375B (en) |
WO (1) | WO2012142197A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8784336B2 (en) | 2005-08-24 | 2014-07-22 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
US10751509B2 (en) | 2007-11-26 | 2020-08-25 | C. R. Bard, Inc. | Iconic representations for guidance of an indwelling medical device |
US8781555B2 (en) | 2007-11-26 | 2014-07-15 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
ES2557084T3 (en) | 2007-11-26 | 2016-01-21 | C. R. Bard, Inc. | Integrated system for intravascular catheter placement |
US9521961B2 (en) | 2007-11-26 | 2016-12-20 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
US9649048B2 (en) | 2007-11-26 | 2017-05-16 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
WO2010022370A1 (en) | 2008-08-22 | 2010-02-25 | C.R. Bard, Inc. | Catheter assembly including ecg sensor and magnetic assemblies |
US9532724B2 (en) | 2009-06-12 | 2017-01-03 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
EP2464407A4 (en) | 2009-08-10 | 2014-04-02 | Bard Access Systems Inc | Devices and methods for endovascular electrography |
WO2011097312A1 (en) | 2010-02-02 | 2011-08-11 | C.R. Bard, Inc. | Apparatus and method for catheter navigation and tip location |
EP2912999B1 (en) | 2010-05-28 | 2022-06-29 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
EP2913000B1 (en) | 2010-05-28 | 2020-02-12 | C.R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
WO2012024577A2 (en) | 2010-08-20 | 2012-02-23 | C.R. Bard, Inc. | Reconfirmation of ecg-assisted catheter tip placement |
WO2012145077A1 (en) | 2011-04-22 | 2012-10-26 | Topera, Inc. | Method for detection of cardiac rhythm disorders using basket style cardiac mapping catheter |
US8923959B2 (en) * | 2012-08-27 | 2014-12-30 | Birinder Robert Boveja | Methods and system for real-time cardiac mapping |
CN105873505A (en) * | 2013-11-01 | 2016-08-17 | 皇家飞利浦有限公司 | System for determining electrical characteristics on a surface of a heart |
ES2811323T3 (en) | 2014-02-06 | 2021-03-11 | Bard Inc C R | Systems for the guidance and placement of an intravascular device |
US10973584B2 (en) | 2015-01-19 | 2021-04-13 | Bard Access Systems, Inc. | Device and method for vascular access |
CN104783785B (en) * | 2015-04-03 | 2017-04-12 | 白融 | Dual-pole cardiac muscle tissue one-way action potential recording electrode |
CN104783894A (en) * | 2015-04-22 | 2015-07-22 | 杭州睿笛生物科技有限公司 | Electrocardiogram monitoring and automatic protection device for electrical ablation of tumors |
WO2016210325A1 (en) | 2015-06-26 | 2016-12-29 | C.R. Bard, Inc. | Connector interface for ecg-based catheter positioning system |
WO2017056762A1 (en) * | 2015-10-02 | 2017-04-06 | ソニー株式会社 | Medical control device, control method, program and medical control system |
EP3344136B1 (en) * | 2015-10-07 | 2020-07-01 | St. Jude Medical, Cardiology Division, Inc. | Methods and systems for mapping cardiac repolarization |
US11000207B2 (en) | 2016-01-29 | 2021-05-11 | C. R. Bard, Inc. | Multiple coil system for tracking a medical device |
SG11201807618QA (en) * | 2016-03-15 | 2018-10-30 | Epix Therapeutics Inc | Improved devices, systems and methods for irrigated ablation |
CN107271798B (en) * | 2016-04-08 | 2019-10-22 | 首都医科大学 | A kind of monophasic action potential record system |
CN109996570B (en) * | 2016-11-23 | 2021-06-29 | 墨尼克医疗用品有限公司 | Method and system for managing patient compliance |
US10645017B2 (en) | 2018-05-09 | 2020-05-05 | Biosig Technologies, Inc. | Systems, apparatus, and methods for conveying biomedical signals between a patient and monitoring and treatment devices |
CN112867443B (en) | 2018-10-16 | 2024-04-26 | 巴德阿克塞斯系统股份有限公司 | Safety equipment connection system for establishing electrical connection and method thereof |
US10687765B1 (en) * | 2019-09-24 | 2020-06-23 | Biosense Webster (Israel) Ltd. | Graphical user interface for parallel electroanatomical mappings |
CN111882559B (en) * | 2020-01-20 | 2023-10-17 | 深圳数字生命研究院 | ECG signal acquisition method and device, storage medium and electronic device |
US11263749B1 (en) * | 2021-06-04 | 2022-03-01 | In-Med Prognostics Inc. | Predictive prognosis based on multimodal analysis |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6950689B1 (en) * | 1998-08-03 | 2005-09-27 | Boston Scientific Scimed, Inc. | Dynamically alterable three-dimensional graphical model of a body region |
US6152882A (en) | 1999-01-26 | 2000-11-28 | Impulse Dynamics N.V. | Apparatus and method for chronic measurement of monophasic action potentials |
US7001383B2 (en) * | 2002-10-21 | 2006-02-21 | Biosense, Inc. | Real-time monitoring and mapping of ablation lesion formation in the heart |
US7599730B2 (en) | 2002-11-19 | 2009-10-06 | Medtronic Navigation, Inc. | Navigation system for cardiac therapies |
RS49856B (en) | 2004-01-16 | 2008-08-07 | Boško Bojović | METHOD AND DEVICE FOR VISUAL THREE-DIMENSIONAL PRESENTATlON OF ECG DATA |
US7225014B1 (en) | 2004-05-18 | 2007-05-29 | Pacesetter, Inc. | Anti-arrhythmia therapy based on spatial and/or temporal information |
US7831294B2 (en) | 2004-10-07 | 2010-11-09 | Stereotaxis, Inc. | System and method of surgical imagining with anatomical overlay for navigation of surgical devices |
US8038625B2 (en) * | 2005-09-15 | 2011-10-18 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for three-dimensional mapping of electrophysiology information |
CN2897151Y (en) | 2006-03-10 | 2007-05-09 | 上海莱恩生物医学科技有限公司 | Heart connecting conduct operation station |
CN106725448B (en) | 2006-05-17 | 2020-01-31 | 圣朱德医疗有限公司房颤分公司 | System and method for mapping electrophysiological information onto complex geometries |
US7774051B2 (en) | 2006-05-17 | 2010-08-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for mapping electrophysiology information onto complex geometry |
WO2008017999A1 (en) | 2006-08-08 | 2008-02-14 | Koninklijke Philips Electronics N.V. | Registration of electroanatomical mapping points to corresponding image data |
US7831076B2 (en) | 2006-12-08 | 2010-11-09 | Biosense Webster, Inc. | Coloring electroanatomical maps to indicate ultrasound data acquisition |
KR101490374B1 (en) | 2007-03-26 | 2015-02-05 | 보스톤 싸이엔티픽 리미티드 | High resolution electrophysiology catheter |
AU2009302220B2 (en) | 2008-10-09 | 2014-03-27 | The Regents Of The University Of California | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders |
US9173574B2 (en) * | 2009-04-22 | 2015-11-03 | Rodrigo E. Teixeira | Mechanical health monitor apparatus and method of operation therefor |
US8280477B2 (en) | 2009-07-29 | 2012-10-02 | Medtronic Cryocath Lp | Mono-phasic action potential electrogram recording catheter, and method |
-
2011
- 2011-04-12 US US13/084,853 patent/US10039502B2/en active Active
-
2012
- 2012-04-12 CN CN201280027415.7A patent/CN103648375B/en active Active
- 2012-04-12 EP EP12716167.7A patent/EP2696753B1/en active Active
- 2012-04-12 WO PCT/US2012/033171 patent/WO2012142197A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN103648375B (en) | 2016-11-16 |
EP2696753A1 (en) | 2014-02-19 |
WO2012142197A1 (en) | 2012-10-18 |
US20120265084A1 (en) | 2012-10-18 |
CN103648375A (en) | 2014-03-19 |
US10039502B2 (en) | 2018-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2696753B1 (en) | System for ELECTROPHYSIOLOGICAL SIGNAL PROCESSING AND UTILIZATION OF A MONOPHASIC ACTION POTENTIAL | |
US11931157B2 (en) | Cardiac analysis user interface system and method | |
JP7325950B2 (en) | Systems and methods for interactive event timelines | |
EP3797691B1 (en) | 3d intracardiac activity presentation | |
US9913589B2 (en) | Device and method for the geometric determination of electrical dipole densities on the cardiac wall | |
US10588531B2 (en) | Methods and systems for determining prevalence of cardiac phenomena | |
EP3087913B1 (en) | Ventricular electrical activity indicator | |
US20050228251A1 (en) | System and method for displaying a three-dimensional image of an organ or structure inside the body | |
EP3185760B1 (en) | Signal characterization to facilitate therapy delivery | |
US20200275851A1 (en) | Systems and methods for displaying ep maps using confidence metrics | |
CN111297471A (en) | Display of arrhythmia type |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20131112 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20170728 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: DAVIE, SCOTT W. Inventor name: STEWART, MARK T. Inventor name: DESROCHERS, GILLES |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602012076689 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61B0005040800 Ipc: A61B0005000000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/00 20060101AFI20210416BHEP |
|
INTG | Intention to grant announced |
Effective date: 20210512 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602012076689 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1429878 Country of ref document: AT Kind code of ref document: T Effective date: 20211015 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20210915 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1429878 Country of ref document: AT Kind code of ref document: T Effective date: 20210915 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211216 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220115 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220117 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602012076689 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 |
|
26N | No opposition filed |
Effective date: 20220616 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220412 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20220430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220412 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220430 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220412 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220412 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20120412 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210915 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240320 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240320 Year of fee payment: 13 |